# FDA Inspection 1134217 - Andrew Alexis, M.D. - October 29, 2020

Source: https://www.keypedia.com/records/fda_inspections/andrew-alexis-md/7c478445-b6b1-4277-a1fc-db86965e93ff
Source feed: FDA_Inspections

> FDA Inspection 1134217 for Andrew Alexis, M.D. on October 29, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1134217
- Company Name: Andrew Alexis, M.D.
- Inspection Date: 2020-10-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/andrew-alexis-md/b0eb0043-644c-4849-a7eb-788a403de1a1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c